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Abstract 
Background: A ruptured hepatocellular carcinoma (HCC) is often fatal. In addition to surgery and transarterial embo‑
lization, radiofrequency ablation (RFA) might be another option for treating a ruptured HCC. Unfortunately, conven‑
tional RFA has a limited ablation zone; as such, it is rarely used to treat ruptured tumors.
Case presentation: This case was a 60‑year‑old man who had a large, ruptured HCC in which hydrochloric acid 
(HCl)‑enhanced RFA successfully controlled the bleeding and made the tumor completely necrotic.
Conclusion: Considering the effectiveness of HCl‑enhanced RFA in achieving hemostasis and tumor ablation, it 
might be a new option for treating large, ruptured HCCs.
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Background
Liver injuries are common and often result in abdomi-
nal pain, bleeding, hypotension, and other conditions 
requiring immediate attention. Hepatic hemorrhage 
most commonly occurs because of blunt trauma or the 
spontaneous rupture of hepatic neoplasms, including 
hepatocellular carcinoma (HCC), adenoma, focal nodular 
hyperplasia, and hemangioma.
 In Asia and Africa, the most common neoplastic 
cause of hepatic hemorrhage is HCC, owing to the high 
prevalence of the disease [1]. The occurrence rate of 
spontaneously ruptured HCC ranges from 3% to 14.5%; 
a ruptured HCC with intraperitoneal hemorrhage is a 
life-threatening complication with a 30-day hospital mor-
tality between 31% and 67% [2, 3]. Several factors are 
associated with hemorrhagic rupture of HCC, includ-
ing trauma, large tumor size, vascular invasion, multiple 
nodules, prior transarterial chemoembolization (TACE), 
portal venous hypertension, and vascular injury [3, 4]. 
Hepatic hemorrhage related to a ruptured HCC can rap-
idly cause hemodynamic instability that requires emer-
gency treatment.
Treatment options for ruptured hemorrhagic HCC 
include packing, plication, emergent hepatic artery liga-
tion, hepatectomy, transarterial embolization (TAE), and 
radiofrequency ablation (RFA) [3, 5, 6]. In some cases, 
TAE and surgery are not effective. Moreover, a 3-cm 
ablative zone produced by a single RFA probe or a 5-cm 
ablative zone obtained with a cluster of probes is not suf-
ficient to ablate a large tumor. However, hydrochloric 
acid (HCl)-enhanced RFA has a much larger ablation 
zone, making it potentially suitable for controlling bleed-
ing from a large, ruptured HCC.
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Case report
On December 13, 2013, a 60-year-old man presented 
at Sun Yat-sen University Cancer Center with a diag-
nosis of HCC (Barcelona Clinic Liver Cancer stage B; 
Fig. 1), severe cirrhosis, and splenomegaly. On January 
9, 2014, because of his impaired liver function (evalu-
ated as Child-Pugh B) and low platelet count, he under-
went TACE and a partial spleen embolization (PSE). A 
subsequent contrast-enhanced computed tomography 
(CT) scan taken on February 27, 2014 revealed a tumor 
with compact deposition in the upper portion and sub-
optimal deposition in the lower portion (Fig. 2). More-
over, his platelet count increased from 45.0  ×  109/L 
at baseline to 115.0 × 109/L after PSE, which is in the 
normal range, and his carbohydrate antigen concen-
tration decreased from 216.1 to 111.9  U/mL. As the 
patient had Child-Pugh B liver function and moderate 
anemia, we therefore thought that he could tolerate a 
second TACE.
On March 15, 2014, after pre-TACE workup, the 
patient experienced sudden abdominal pain following 
a hard defecation. Based on obvious signs of peritoneal 
irritation and uncoagulated hemorrhagic fluid in the 
perihepatic region obtained under ultrasound-guided 
abdominal paracentesis, a diagnosis of a spontaneously 
ruptured HCC was confirmed. An emergent TAE was 
performed by the physicians on duty. Digital subtrac-
tion angiography (DSA) showed that a large amount of 
Fig. 1 The initial computed tomography (CT) images of the patient with large hepatocellular carcinoma. The coronal a and axil b CT images in the 
arterial phase show a tumor (5.8 cm × 7.6 cm) occupying liver segments VI–VII (yellow arrows) with multifocal lesions. The inferior portion of the 
tumor protrudes through the liver contour adjacent to the ipsilateral renal fascia (yellow arrowhead). Splenomegaly can be seen as well (red arrow)
Fig. 2 The follow‑up CT images after transarterial chemoembolization (TACE). The coronal a and axil b CT images show the tumor with inhomo‑
geneous deposition of lipiodol, the compact upper portion (yellow arrow) and the lower portion (yellow curved arrow) without lipiodol deposition 
which was still enhanced in the arterial phase. The protruded tumor was located adjacent to the upper polar of the right kidney (yellow arrowhead). 
The spleen was inactive after partial embolization (red arrow)
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intraperitoneal hemorrhage had pushed the liver paren-
chyma away from the abdominal wall (Fig.  3). Unfortu-
nately, the patient became hemodynamically unstable 
during the next 12  h, and increasing ascites and active 
bleeding were confirmed by ultrasound. His liver func-
tion deteriorated to Child-Pugh C, making surgery 
inappropriate. Considering several reports of ruptured 
HCC being controlled by emergent RFA and our experi-
ence with ablation-expanding, HCl-enhanced RFA, we 
decided to try to control his bleeding with HCl-enhanced 
RFA [6, 7].
Written informed consent to the procedure and con-
sent to publish were obtained from the patient and his 
family. The HCl-enhanced RFA procedure was approved 
by the Clinical Research Ethics Committee of Sun Yat-
sen Cancer Center.
A large ablative zone can be achieved with HCl-
enhanced RFA by constantly infusing HCl at a rate of 
0.2  mL/min and simultaneously delivering radiofre-
quency (RF) energy with an RF generator (Model 1500X, 
AngioDynamics, RITA Medical Systems, Queensbury, 
NY, USA) coupled with a monopolar perfusion electrode 
(UniBlate, RITA Medical Systems). We used 10% HCl 
(Huayi Medical Auxiliary Materials Manufacturing Co., 
Ltd, Chengdu, Sichuan, China) as the perfusate, which 
was diffused in the center of the tumor. HCl is thought 
to increase the ionic concentration around the electrode 
and delay charring of the surrounding tissue [7]. With the 
patient under local anesthesia, HCl-enhanced RFA was 
applied for 100 min with a constant stable output power 
of 100  W and a temperature of 103  °C to the poten-
tial bleeding site, which was probably the portion of the 
protruding liver contour without any lipiodol deposition 
(Fig. 4).
After CT-guided, HCl-enhanced RFA, the patient’s 
vital signs returned to normal within 24  h. The peri-
toneal drainage fluid changed from hemorrhagic dark 
red to light yellow, which confirmed control of the 
bleeding. Additional conservative treatments were 
administered during follow-up. Moreover, magnetic 
resonance imaging performed 1, 6, and 9 months later 
showed a necrotic tumor with little liquid surround-
ing the hepatic capsule (Fig. 5). By the end of October 
2015, the patient had been alive for 16 months and had 
an acceptable quality of life, with Child-Pugh B liver 
function.
Discussion
Spontaneous tumor rupture is a potential consequence of 
HCC and results in a high mortality [3]. The most com-
mon mechanisms for hemoperitoneum in HCC rupture 
are tumor pseudo-capsule disruption and tearing of a 
parasitic feeding artery. Kanematsu et  al. [8] hypothe-
sized that several features visible on CT images portend 
HCC rupture: a large tumor size, an area of protruded 
tumor, and a large extent of contact between the tumor 
and the liver surface. Consistent with this hypothesis, the 
large HCC in this case eventually ruptured.
Hemostasis is the primary consideration in HCC rup-
ture, and adequate bleeding controlling is vital to patient 
prognosis. As treatment opinions regarding ruptured 
HCC have evolved and as new clinical technologies 
have been adopted, treatment strategies for ruptured 
HCC have become increasingly diverse, including vari-
ous conservative, surgical, and minimally invasive meas-
urements. In 1965, Ong et al. [9] advocated packing the 
ruptured liver as an efficient method to control hemor-
rhage; then, in 1972, they advocated ligating the hepatic 
artery. However, with simple packing, they found a high 
rate of re-bleeding. Moreover, in some cases in the 1970s, 
direct plication by overlying the capsule was determined 
to achieve hemostasis [8]. Because the results were disap-
pointing, though, given the friability of HCC, this method 
is now seldom used. Although emergent hepatectomy 
remains the most effective treatment for ruptured HCC, 
it accounts for 7% of the hospital mortality [3].
With the increasing application of interventional tech-
niques in the last 20 years, TAE emerged as another pro-
cedure that could potentially achieve hemostasis in a 
ruptured HCC, having a success rate between 53% and 
100% and resulting in a lower 30-day hospital mortal-
ity (0%–37%) than those of surgery [5]. The advantages 
of TAE over surgery are that it is minimally invasive and 
directly occludes the feeding vessels, which means that 
surgery can be avoided in patients at high risk.
Fig. 3 The digital subtraction angiography image of the emergent 
transarterial embolization for arresting bleeding. No lipiodol deposi‑
tion is observed in the upper portion of hepatocellular carcinoma 
(curved arrow). The feeding arterial vessel is difficult to trace (arrow-
head). The crumpled hepatic parenchyma is separated from the 
abdominal wall by the hemoperitoneum (twin arrows)
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Recently, several studies reported successful hemosta-
sis using RFA [6, 10]. In addition, Chueng et al. [1] found 
that RFA is safe and effective for achieving hemostasis in 
ruptured HCC with satisfactory survival outcomes, and 
therefore they proposed RFA as a first-line option for 
treating a ruptured HCC. However, needle placement 
with laparoscopic RFA is less accurate than that with 
image-guided percutaneous RFA, which has particular 
advantages for treating lesions within the deep hepatic 
parenchyma.
In the present case, because our patient had severe cir-
rhosis, he could not tolerate surgery. Moreover, a failed 
TAE impaired his hepatic function. As Leung et al. [11] 
reported, non-super-selective TAE as regional therapy is 
harmful to patients. They thought that there was typically 
only one opportunity to achieve hemostasis with TAE, 
and that more than one attempt would harm the normal 
hepatic parenchyma.
When the tumors are large or peripherally located, 
extrahepatic collateral arteries commonly supply HCCs 
[12]. In our case, both enhanced CT scanning and 
DSA revealed a filling defect on the lower portion of 
the tumor. Thus, considering the location of the non-
enhanced tumor, collateral vessels supplying this portion 
were probably branches of the adrenal artery.
Fig. 4 The CT images of the hydrochloric acid (HCl)‑enhanced radiofrequency ablation (RFA) procedure. a The RFA electrode (arrow) is inserted into 
the portion without lipiodol deposition. b The loose necrotic HCC lesion after HCl‑enhanced RFA procedure hangs on the renal region (twin arrows)
Fig. 5 The follow‑up magnetic resonance images (MRI). The coronal MRI at 1 (a), 6 (b), and 9 months (c) after HCl‑enhanced RFA show reduced 
lesion size and a satisfactory tumor capsule beyond the hepatic contour (curved arrow). The gradually distinct margin of the upper renal fascia is also 
visible (arrowhead). Perihepatic and perirenal ascites are decreased (twin arrows)
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After TAE failed to restore hemostasis, and consider-
ing both the patient’s overall condition and the results 
of our previous clinical studies with HCl-enhanced 
RFA, we determined that CT-guided RFA was a reason-
able treatment option. A prior PSE had increased the 
patient’s platelet count to the level on which coagula-
tion was adequate to proceed with RFA [13]. However, 
currently, the maximum ablative zone obtainable with 
conventional monopolar RFA is 3 cm in diameter. Thus, 
in this case, the 7-cm diameter tumor would be diffi-
cult to ablate in one session. Additionally, our previous 
experiments showed that infusing diluted HCl instead 
of natural saline into the ablation zone during RFA with 
monopolar perfusion electrodes could enlarge the abla-
tion size (mean ±  standard deviation) from 3.49 ± 0.07 
to 6.85 ±  0.32  cm under the same power and time set-
tings (30  W and 30  min) [14]. Given these considera-
tions and the patient’s large hepatic mass, we decided to 
use HCl-enhanced RFA instead of natural saline-infused 
RFA. In our case, HCl-enhanced RFA damaged neither 
the nearby duodenum nor the renal fascia. This result 
may relate to the progressive decrease in temperature 
from the center to the periphery and to the insulating 
effects of the fibrous fascia.
In contrast to normal saline, HCl functions as a chemi-
cal ablation agent and is capable of producing an ablative 
lesion itself [15]. Furthermore, HCl is a strong electrolyte 
whose conductivity is about three times that of natural 
saline, which can increase the conductivity of RF energy. 
Thus, when HCl is instilled around the RF electrode, the 
RF energy expands from a needle shape into a spherical 
shape. This enlarged spherical volume increases contact 
area between the RF source and the tissue intended for 
ablation. In turn, this increased contact area transfers and 
sustains RF energy much longer (100 min in this case) than 
normal saline, lengthening the charred area and prolong-
ing the delivery of energy, thus creating a larger ablation 
zone than any other current RFA method. Therefore, our 
success in treating this ruptured HCC suggests that a treat-
ment pattern of HCl-enhanced RFA followed by TAE or 
combined with surgery could be considered in the future.
As in the present case, for patients with a cirrhotic liver, 
HCC is often associated with survival of less than 30 days 
[3]. However, our patient has survived for 16  months. 
Treatment with HCl-enhanced RFA achieved immedi-
ate and total hemostasis and completely ablated the large, 
bleeding tumor. In addition, as a regional therapy, HCl-
enhanced RFA resulted in well-preserved liver function; 
thus, the patient could recuperate rapidly.
In conclusion, HCl-enhanced RFA appears to be a safe 
and effective treatment for controlling bleeding after 
spontaneous rupture of large HCC. However, further 
research is necessary to confirm our findings.
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